CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 195 filers reported holding CHEMOCENTRYX INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $16,556,000 | +115.4% | 320,461 | +3.3% | 0.00% | +200.0% |
Q2 2022 | $7,685,000 | -16.2% | 310,129 | -15.2% | 0.00% | 0.0% |
Q1 2022 | $9,166,000 | -31.5% | 365,634 | -0.5% | 0.00% | 0.0% |
Q4 2021 | $13,378,000 | +107.7% | 367,423 | -2.4% | 0.00% | 0.0% |
Q3 2021 | $6,440,000 | +8.1% | 376,622 | -15.3% | 0.00% | 0.0% |
Q2 2021 | $5,957,000 | -73.4% | 444,898 | +2.0% | 0.00% | -50.0% |
Q1 2021 | $22,355,000 | -10.4% | 436,276 | +8.2% | 0.00% | -33.3% |
Q4 2020 | $24,962,000 | +62.0% | 403,128 | +43.4% | 0.00% | +50.0% |
Q3 2020 | $15,408,000 | -57.7% | 281,162 | -55.6% | 0.00% | -60.0% |
Q2 2020 | $36,420,000 | +439.6% | 632,957 | +276.8% | 0.01% | +400.0% |
Q1 2020 | $6,749,000 | +86.3% | 167,964 | +83.4% | 0.00% | – |
Q4 2019 | $3,623,000 | -42.1% | 91,600 | -80.1% | 0.00% | -100.0% |
Q1 2018 | $6,258,000 | +74.0% | 460,141 | -28.9% | 0.00% | 0.0% |
Q3 2013 | $3,596,000 | -81.0% | 646,800 | -51.8% | 0.00% | -66.7% |
Q2 2013 | $18,974,000 | – | 1,341,800 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |